New radiation drug trial offers hope for kids with tough cancers
NCT ID NCT03478462
Summary
This study is testing a new drug called CLR 131 in children and young adults whose cancers have come back or haven't responded to standard treatments. The drug is designed to deliver radiation directly to cancer cells. The main goals are to find a safe dose and see if the drug shows early signs of helping control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital at Westmead
Westmead, New South Wales, 2145, Australia
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Duke University
Chapel Hill, North Carolina, 27708, United States
-
Hospital for Sick Children
Toronto, Ontario, M5G1X8, Canada
-
Lucile Packard Children's Hospital
Palo Alto, California, 94304, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Texas Children's Hospital
Houston, Texas, 77030, United States
-
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.